CEL-SCI Corp. (CVM)
1.65
+0.04
(+2.48%)
USD |
NYAM |
Aug 27, 13:13
CEL-SCI Market Cap : 29.02M for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 28.32M |
| August 25, 2026 | 26.03M |
| August 24, 2026 | 24.27M |
| August 21, 2026 | 24.98M |
| August 20, 2026 | 25.68M |
| August 19, 2026 | 28.85M |
| August 18, 2026 | 27.97M |
| August 17, 2026 | 27.26M |
| August 14, 2026 | 27.09M |
| August 13, 2026 | 26.21M |
| August 12, 2026 | 26.03M |
| August 11, 2026 | 26.73M |
| August 10, 2026 | 12.65M |
| August 07, 2026 | 14.61M |
| August 06, 2026 | 13.67M |
| August 05, 2026 | 12.91M |
| August 04, 2026 | 11.55M |
| August 03, 2026 | 10.62M |
| July 31, 2026 | 9.852M |
| July 30, 2026 | 10.36M |
| July 29, 2026 | 9.682M |
| July 28, 2026 | 10.19M |
| July 27, 2026 | 10.02M |
| July 24, 2026 | 10.02M |
| July 23, 2026 | 10.11M |
| Date | Value |
|---|---|
| July 22, 2026 | 10.45M |
| July 21, 2026 | 10.62M |
| July 20, 2026 | 10.79M |
| July 17, 2026 | 9.937M |
| July 16, 2026 | 9.767M |
| July 15, 2026 | 9.767M |
| July 14, 2026 | 9.767M |
| July 13, 2026 | 10.36M |
| July 10, 2026 | 11.72M |
| July 09, 2026 | 11.47M |
| July 08, 2026 | 11.97M |
| July 07, 2026 | 10.87M |
| July 06, 2026 | 10.79M |
| July 02, 2026 | 9.682M |
| July 01, 2026 | 8.917M |
| June 30, 2026 | 8.832M |
| June 29, 2026 | 9.172M |
| June 26, 2026 | 9.427M |
| June 25, 2026 | 8.275M |
| June 24, 2026 | 8.450M |
| June 23, 2026 | 8.663M |
| June 22, 2026 | 8.578M |
| June 18, 2026 | 8.832M |
| June 17, 2026 | 9.342M |
| June 16, 2026 | 8.578M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 342.20M |
| Amgen, Inc. | 237.43B |
| Anika Therapeutics, Inc. | 285.19M |
| BioCryst Pharmaceuticals, Inc. | 2.476B |
| Imunon, Inc. | 7.558M |
Market Cap Related Metrics
| Price to Book Value | 2.649 |
| Price | 1.65 |
| Earnings Yield | -156.5% |